PT - JOURNAL ARTICLE AU - Naif Saad ALGhasab AU - Leen A. Altamimi AU - Mohammed Salem Alharbi AU - Sulaman S. ALMesned AU - Aditya K. Khetan TI - Venous thromboembolism in COVID-19 AID - 10.15537/smj.2022.43.9.20220316 DP - 2022 Sep 01 TA - Saudi Medical Journal PG - 979--990 VI - 43 IP - 9 4099 - http://smj.org.sa/content/43/9/979.short 4100 - http://smj.org.sa/content/43/9/979.full SO - Saudi Med J2022 Sep 01; 43 AB - Objectives: To summarize cases of venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT) among coronavirus disease (COVID-19) patients and discuss their symptoms, diagnostic method, clinical features, and prognosis.Methods: All major databases were searched for relevant studies published between December 1, 2019 and May 5, 2021.Results: A total of 233 articles were identified, 22 describing 48 patients were included. A total of 79.1% had PE and 20.9% had DVT. Most patients were men, with a mean age of 56 years. Comorbidities were present in 70.8%, and 85.4% had at least one risk factor of VTE. 56.3% had received anticoagulation therapy. Most patients were treated in the general ward. Complications occurred in 27.1% of the patients, and recovery was achieved in 80.4%.Conclusion: Venous thromboembolism must be suspected even in patients who had received prior anticoagulant regimens or in stable cases, especially in males, the elderly, and patients with comorbidities and high D-dimer levels.